253 related articles for article (PubMed ID: 26538531)
1. Tumor progression, metastasis, and modulators of epithelial-mesenchymal transition in endometrioid endometrial carcinoma: an update.
Makker A; Goel MM
Endocr Relat Cancer; 2016 Feb; 23(2):R85-R111. PubMed ID: 26538531
[TBL] [Abstract][Full Text] [Related]
2. Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma.
Montserrat N; Mozos A; Llobet D; Dolcet X; Pons C; de Herreros AG; Matias-Guiu X; Prat J
Hum Pathol; 2012 May; 43(5):632-43. PubMed ID: 21940036
[TBL] [Abstract][Full Text] [Related]
3. Association between Morphological Patterns of Myometrial Invasion and Cancer Stem Cell Markers in Endometrial Endometrioid Carcinoma.
Park JY; Hong D; Park JY
Pathol Oncol Res; 2019 Jan; 25(1):123-130. PubMed ID: 28990139
[TBL] [Abstract][Full Text] [Related]
4. [Microcystic, elongated and fragmented invasion pattern in endometrial carcinoma: the clinicopathology analysis].
Zhang XB; Zhao CL; Qi XL; Qin Y; Wang Y; Shen DH
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):811-815. PubMed ID: 30585018
[No Abstract] [Full Text] [Related]
5. Clinicopathological significance and prognostic value of myoinvasive patterns in endometrial endometrioid carcinoma.
Amălinei C; Aignătoaei AM; Balan RA; Giuşcă SE; Lozneanu L; Avădănei ER; Căruntu ID
Rom J Morphol Embryol; 2018; 59(1):13-22. PubMed ID: 29940607
[TBL] [Abstract][Full Text] [Related]
6. Tumor Budding is a Valuable Diagnostic Parameter in Prediction of Disease Progression of Endometrial Endometrioid Carcinoma.
Park JY; Hong DG; Chong GO; Park JY
Pathol Oncol Res; 2019 Apr; 25(2):723-730. PubMed ID: 30604272
[TBL] [Abstract][Full Text] [Related]
7. Lymphovascular space invasion in microcystic elongated and fragmented (MELF)-pattern well-differentiated endometrioid adenocarcinoma is associated with a higher rate of lymph node metastasis.
Hertel JD; Huettner PC; Pfeifer JD
Int J Gynecol Pathol; 2014 Mar; 33(2):127-34. PubMed ID: 24487466
[TBL] [Abstract][Full Text] [Related]
8. Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion.
Quick CM; May T; Horowitz NS; Nucci MR
Int J Gynecol Pathol; 2012 Jul; 31(4):337-43. PubMed ID: 22653347
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
[TBL] [Abstract][Full Text] [Related]
10. Patterns of myoinvasion in endometrial adenocarcinoma: recognition and implications.
Cole AJ; Quick CM
Adv Anat Pathol; 2013 May; 20(3):141-7. PubMed ID: 23574770
[TBL] [Abstract][Full Text] [Related]
11. Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma.
Han G; Lim D; Leitao MM; Abu-Rustum NR; Soslow RA
Histopathology; 2014 Feb; 64(3):389-98. PubMed ID: 24215212
[TBL] [Abstract][Full Text] [Related]
12. Regulation of epithelial-mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs.
Kent CN; Guttilla Reed IK
Clin Transl Oncol; 2016 Nov; 18(11):1056-1061. PubMed ID: 26856598
[TBL] [Abstract][Full Text] [Related]
13. Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer.
Dong P; Kaneuchi M; Xiong Y; Cao L; Cai M; Liu X; Guo SW; Ju J; Jia N; Konno Y; Watari H; Hosaka M; Sudo S; Sakuragi N
Carcinogenesis; 2014 Apr; 35(4):760-8. PubMed ID: 24220291
[TBL] [Abstract][Full Text] [Related]
14. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-type plasminogen activator resulting from endometrial carcinogenesis enhances tumor invasion and correlates with poor outcome of endometrial carcinoma patients.
Huang CY; Chang MC; Huang WY; Huang CT; Tang YC; Huang HD; Kuo KT; Chen CA; Cheng WF
Sci Rep; 2015 Jun; 5():10680. PubMed ID: 26033187
[TBL] [Abstract][Full Text] [Related]
16. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-to-mesenchymal transition and stem cells in endometrial cancer.
Mirantes C; Espinosa I; Ferrer I; Dolcet X; Prat J; Matias-Guiu X
Hum Pathol; 2013 Oct; 44(10):1973-81. PubMed ID: 23845467
[TBL] [Abstract][Full Text] [Related]
19. Folate receptor α expression and significance in endometrioid endometrium carcinoma and endometrial hyperplasia.
Senol S; Ceyran AB; Aydin A; Zemheri E; Ozkanli S; Kösemetin D; Sehitoglu I; Akalin I
Int J Clin Exp Pathol; 2015; 8(5):5633-41. PubMed ID: 26191275
[TBL] [Abstract][Full Text] [Related]
20. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role.
Espinosa I; José Carnicer M; Catasus L; Canet B; D'angelo E; Zannoni GF; Prat J
Am J Surg Pathol; 2010 Nov; 34(11):1708-14. PubMed ID: 20962622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]